China National Pharmaceutical Group Co Ltd (Sinopharm) boasts nearly 30 core manufacturing enterprises, including Shanghai Shyndec Pharmaceutical Co Ltd and Southwest Pharmaceutical Co Ltd.

The company has established a globally leading production capacity for antibiotic raw materials. It stands out for its world-premier clavulanic acid production capacity, while also securing a spot among the top three globally for the production of 7-ACA and 6-APA.

Additionally, Sinopharm owns the nation's largest production and marketing system for anesthetic and psychotropic substances. It takes pride in its integrated production system, which encompasses APIs matched with anesthetic and psychotropic preparations and ensures full coverage of all dosage forms.